These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38455307)

  • 1. Breaking the cycle of malaria treatment failure.
    Boni MF
    Front Epidemiol; 2022; 2():1041896. PubMed ID: 38455307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria Surveillance - United States, 2018.
    Mace KE; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2022 Sep; 71(8):1-35. PubMed ID: 36048717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial drug resistance in Africa: key lessons for the future.
    Takala-Harrison S; Laufer MK
    Ann N Y Acad Sci; 2015 Apr; 1342():62-7. PubMed ID: 25891142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum population-level use of artemisinin combination therapies: a modelling study.
    Nguyen TD; Olliaro P; Dondorp AM; Baird JK; Lam HM; Farrar J; Thwaites GE; White NJ; Boni MF
    Lancet Glob Health; 2015 Dec; 3(12):e758-66. PubMed ID: 26545449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin-based combination therapy for treating uncomplicated malaria.
    Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: A network meta-analysis.
    Naing C; Whittaker MA; Htet NH; Aye SN; Mak JW
    PLoS One; 2019; 14(12):e0225882. PubMed ID: 31856172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of falciparum malaria to different antimalarials in Myanmar.
    Ejov MN; Tun T; Aung S; Sein K
    Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria.
    Tindana P; Guissou R; Bolarinwa OA; Tou F; de Haan F; Dhorda M; Dondorp AM; Amaratunga C; Mokuolu OA; Ouedraogo JB; Cheah PY
    PLoS One; 2022; 17(9):e0273249. PubMed ID: 36083995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso.
    Kaboré JMT; Siribié M; Hien D; Soulama I; Barry N; Baguiya A; Tiono AB; Burri C; Tchouatieu AM; Sirima SB
    Trop Med Infect Dis; 2023 Mar; 8(4):. PubMed ID: 37104321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria surveillance--United States, 2012.
    Cullen KA; Arguin PM;
    MMWR Surveill Summ; 2014 Dec; 63(12):1-22. PubMed ID: 25474160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.